Avid Bioservices, Inc. (CDMO) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Verve Therapeutics, Inc.

Adaptive Biotechnologies Corp.

Editas Medicine, Inc.

Wave Life Sciences Ltd.

Kura Oncology, Inc.

Curis, Inc.

Novavax, Inc.

Avid Bioservices, Inc.

Sana Biotechnology, Inc.

Cabaletta Bio, Inc.

Cassava Sciences, Inc.

Why is Avid Bioservices, Inc. ?

With a fall in Net Profit of NAN%, the company declared Very Negative results in Oct 24

The company has declared negative results for the last 9 consecutive quarters
NET PROFIT(HY) At USD -22.94 MM has Grown at -97.03%
ROCE(HY) Lowest at -133.29%
DEBT-EQUITY RATIO (HY) Highest at 383.65 %

Risky - Not traded in last 10 days

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 0%, its profits have fallen by -1200.7%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Avid Bioservices, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Avid Bioservices, Inc.

99.2%

1.74

57.15%

S&P 500

13.22%

0.61

20.23%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

18.50%

EBIT Growth (5y)

-218.87%

EBIT to Interest (avg)

0.56

Debt to EBITDA (avg)

2.16

Net Debt to Equity (avg)

2.72

Sales to Capital Employed (avg)

0.50

Tax Ratio

100.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

12.09%

ROE (avg)

18.60%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

17.83

EV to EBIT

-45.19

EV to EBITDA

-118.09

EV to Capital Employed

5.52

EV to Sales

6.12

PEG Ratio

Dividend Yield

98.15%

ROCE (Latest)

-12.22%

ROE (Latest)

-339.34%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Avid Bioservices, Inc.

Operating Cash Flow

Highest at USD 5.26 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit

At USD -17.41 MM has Grown at 51.71%

over average net sales of the previous four periods of USD -36.04 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Inventory Turnover Ratio

Highest at 4.17%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -63.29% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at USD 3.97 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Depreciation

At USD 3.97 MM has Grown at 40.65%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (USD MM)

Here's what is not working for Avid Bioservices, Inc.

Pre-Tax Profit

At USD -17.41 MM has Fallen at -134.18%

over average net sales of the previous four periods of USD -7.43 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Interest

At USD 3.28 MM has Grown at 33.5%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio

Highest at 383.65 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest

Highest at USD 3.28 MM

in the last five periods and Increased by 33.5% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Profit

Lowest at USD -8.66 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit

Lowest at USD -17.41 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)